Healthcare >> Sector Roundtables >> November 1, 1999
WILLIAM SLATTERY is a Partner at Deerfield Management Company covering
the biotechnology and healthcare based Internet technologies. He began
his career at the laboratory bench, studying complications associated
with End Stage Renal Disease. Mr. Slattery was previously associated
with Amerindo Investment Advisors, Inc., National Medicine Enterprises,
Lifescan/Johnson & Johnson and HMSS, a division of Secomerica. He
received a BSc degree in Biochemistry from the State University of New
York at Albany and attended the Graduate School of Health at Rutgers. Profile
MARGARET MALLOY is a Senior Analyst with Hambrecht & Quist. Previously,
she was associated with Needhan & Company and PaineWebber. She also
conducted research in the field of brain asymmetry and endocrinology at
the University of Chicago. A Chartered Financial Analyst, Ms. Malloy
holds a Bachelor's degree from the University of Chicago. Profile
JAY B. SILVERMAN is a Managing Director and Senior Research Analyst with
Robertson Stephens, covering first-generation biotechnology companies
and other emerging biopharmaceutical firms. Previously, he spent five
years as a Vice President and Senior Analyst for biotechnology and
medical technology with Schroder Wertheim & Company. Mr. Silverman holds
a Bachelor's degree from the Wharton School of the University of
Pennsylvania. Profile
ELISE T. WANG is currently a Managing Director in Equity Research at
Salomon Smith Barney covering the biotechnology industry. Previously,
she was a Managing Director and Senior Research Analyst in the Health
Care Equity Research Group at PaineWebber Incorporated, covering the
biotechnology industry. In 2000, Ms. Wang was voted runner-up in the
Institutional Investor poll in Biotechnology. In addition, Ms. Wang also
achieved recognition in the Wall Street Journal All Star Analyst survey
in Biotechnology for the past three years. Prior to joining Equity
Research at PaineWebber in January of 1996, she was a Vice President in
the Health Sciences Group of the Investment Banking Division of
PaineWebber with responsibility for providing financial advisory work
and services in biotechnology and other healthcare sectors. Ms. Wang
holds a Bachelor of Arts degree in Engineering Sciences with a specialty
in Biomechanics from Harvard University and a Master of Business
Administration degree from Harvard Graduate School of Business. Profile
TWST: Were you surprised by the performance of the biotechnology stocksin 1999?
Ms. Wang: It certainly has been a terrific year. According to the
indices we track, the sector is up about 40%.